Zentalis Pharmaceuticals, Inc. (ZNTL) Reports In-Line Q1 EPS

Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) reported Q1 EPS of ($0.50), in-line with the analyst estimate of ($0.50).

For earnings history and earnings-related data on Zentalis Pharmaceuticals, Inc. (ZNTL) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
• Bread Financial reports lower loss, delinquency rates in July 2026